Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Alchera, Elisa ^a   Imarisio, Chiara ^a   Mandili, Giorgia ^b,c   Merlin, Simone ^a   Chandrashekar, Bangalore R ^a   Novelli, Francesco ^b,c   Follenzi, Antonia ^a   Carini, Rita ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; PROTEOME;

ANTIOXIDANT ACTIVITY; CELL PROTECTION; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; LIPOTOXICITY; LIVER CELL; LIVER CELL DAMAGE; MEDIATOR; PHENOTYPE; PLEIOTROPY; REPERFUSION INJURY; REVIEW; DRUG EFFECTS; HUMAN; INJURIES; LIVER; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION;

CYTOPROTECTION; HEPATOCYTES; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; RECEPTOR, ADENOSINE A2A; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84945978702     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/286746     Document Type: Review

References (67)

1. O. De Rougemont, K. Lehmann, and P. A. Clavien, "Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver," Liver Transplantation, vol. 15, no. 10, pp. 1172-1182, 2009.
2. T. Karatzas, A. A. Neri,M. E. Baibaki, and I. A. Dontas, "Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms," Journal of Surgical Research, vol. 191, no. 2, pp. 399-412, 2014.
3. H. Jaeschke, "Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 284, no. 1, pp. G15-G26, 2003.
4. E. Alchera, C. Dal Ponte, C. Imarisio, E. Albano, and R. Carini, "Molecular mechanisms of liver preconditioning," World Journal of Gastroenterology, vol. 16, no. 48, pp. 6058-6067, 2010.
5. N. Selzner, H. Rudiger, R. Graf, and P.-A. Clavien, "Protective strategies against ischemic injury of the liver," Gastroenterology, vol. 125, no. 3, pp. 917-936, 2003.
6. M. Akhtar, T. Henderson, A. Sutherland, T. Vogel, and P. Friend, "Novel approaches to preventing ischemiareperfusion injury during liver transplantation," Transplantation Proceedings, vol. 45, no. 6, pp. 2083-2092, 2013.
7. D. M. Yellon and A. Dana, "The preconditioning phenomenon: a tool for the scientist or a clinical reality?" Circulation Research, vol. 87, no. 7, pp. 543-550, 2000.
8. C. E. Murry, R. B. Jennings, and K. A. Reimer, "Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium," Circulation, vol. 74, no. 5, pp. 1124-1136, 1986.
9. X. Song, N. Zhang, H. Xu, L. Cao, and H. Zhang, "Combined preconditioning and postconditioning provides synergistic protection against liver ischemic reperfusion injury," International Journal of Biological Sciences, vol. 8, no. 5, pp. 707-718, 2012.
10. A. Franchello, N. Gilbo, E. David et al., "Ischemic Preconditioning (IP) of the liver as a safe and protective technique against Ischemia/Reperfusion Injury (IRI)," American Journal of Transplantation, vol. 9, no. 7, pp. 1629-1639, 2009.
11. O. Scatton, S. Zalinski, D. Jegou et al., "Randomized clinical trial of ischaemic preconditioning in major liver resection with intermittent Pringlemanoeuvre," British Journal of Surgery, vol. 98, no. 9, pp. 1236-1243, 2011.
12. S. O'Neill, S. Leuschner, S. J. McNally, O. J. Garden, S. J. Wigmore, and E. M. Harrison, "Meta-analysis of ischaemic preconditioning for liver resections," British Journal of Surgery, vol. 100, no. 13, pp. 1689-1700, 2013.
13. M. J. Chu, R. Vather, A. J. Hickey, A. R. Phillips, and A. S. Bartlett, "Impact of ischemic preconditioning on outcome in clinical liver surgery: a systematic review," BioMed Research International, vol. 2015, Article ID 370451, 13 pages, 2015.
14. B. B. Fredholm, "Adenosine, an endogenous distress signal, modulates tissue damage and repair," Cell Death and Differentiation, vol. 14, no. 7, pp. 1315-1323, 2007.
15. C. Peralta, G. Hotter, D. Closa, E. Gelp, O. Bulbena, and J. Roselló-Catafau, "Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine," Hepatology, vol. 25, no. 4, pp. 934-937, 1997.
16. C. Peralta, G. Hotter, D. Closa et al., "The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors," Hepatology, vol. 29, no. 1, pp. 126-132, 1999.
17. H. Nakayama, Y. Yamamoto, M. Kume et al., "Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers," Surgery, vol. 126, no. 5, pp. 945-954, 1999.
18. M. L. Hart, C. Much, I. C. Gorzolla et al., "Extracellular adenosine production by ecto-5-nucleotidase protects duringmurine hepatic ischemic preconditioning," Gastroenterology, vol. 135, no. 5, pp. 1739-1750. e3, 2008.
19. R. Carini, M. Grazia De Cesaris, R. Splendore, M. Bagnati, and E. Albano, "Ischemic preconditioning reduces Na+ accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia," Hepatology, vol. 31, no. 1, pp. 166-172, 2000.
20. R. Carini, M. G. de Cesaris, R. Splendore et al., "Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes," Hepatology, vol. 33, no. 1, pp. 131-139, 2001.
21. C. M. Lappas, Y.-J. Day, M. A. Marshall, V. H. Engelhard, and J. Linden, "Adenosine A2 receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation,"The Journal of ExperimentalMedicine, vol. 203, no. 12, pp. 2639-2648, 2006.
22. Y.-J. Day, Y. Li, J. M. Rieger, S. I. Ramos, M. D. Okusa, and J. Linden, "A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury," The Journal of Immunology, vol. 174, no. 8, pp. 5040-5046, 2005.
23. R. J. Schauer, A. L. Gerbes, D. Vonier, M. Op den Winkel, P. Fraunberger, and M. Bilzer, "Induction of cellular resistance against Kupffer cell-derived oxidant stress: a novel concept of hepatoprotection by ischemic preconditioning," Hepatology, vol. 37, no. 2, pp. 286-295, 2003.
24. Z. Ben-Ari,O. Pappo, J. Sulkes, Y. Cheporko, B. A. Vidne, and E. Hochhauser, "Effect of adenosine A2A receptor agonist (CGS) on ischemia/reperfusion injury in isolated rat liver," Apoptosis, vol. 10, no. 5, pp. 955-962, 2005.
25. N. Yun and S.-M. Lee, "Activation of protein kinase C delta reduces hepatocellular damage in ischemic preconditioned rat liver," Journal of Surgical Research, vol. 185, no. 2, pp. 869-876, 2013.
26. F. Serracino-Inglott, I. T. Virlos, N. A. Habib, R. C. N. Williamson, and R. T. Mathie, "Adenosine preconditioning attenuates hepatic reperfusion injury in the rat by preventing the down-regulation of endothelial nitric oxide synthase," BMC Gastroenterology, vol. 2, article 22, 2002.
27. R. Carini, M. G. De Cesaris, R. Splendore et al., "Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning," Gastroenterology, vol. 127, no. 3, pp. 914-923, 2004.
28. G. Baldanzi, E. Alchera, C. Imarisio et al., "Negative regulation of diacylglycerol kinase mediates adenosine-dependent hepatocyte preconditioning," Cell Death and Differentiation, vol. 17, no. 6, pp. 1059-1068, 2010.
29. C. dal Ponte, E. Alchera, A. Follenzi et al., "Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury," Liver Transplantation, vol. 17, no. 4, pp. 474-482, 2011.
30. N. Teoh, A. D. Pena, and G. Farrell, "Hepatic ischemic preconditioning in mice is associated with activation of NF-B, p38 kinase, and cell cycle entry," Hepatology, vol. 36, no. 1, pp. 94-102, 2002.
31. K. Izuishi, M. Fujiwara, M. A. Hossain, H. Usuki, and H. Maeta, "Significance of phosphoinositide 3-kinase pathway on ischemic preconditioning followed by ischemia reperfusion in mice liver," Transplantation Proceedings, vol. 35, no. 1, pp. 132-133, 2003.
32. R. Carini, G. Bellomo, A. Benedetti et al., "Alteration of Na+ homeostasis as a critical step in the development of irreversible hepatocyte injury after adenosine triphosphate depletion," Hepatology, vol. 21, no. 4, pp. 1089-1098, 1995.
33. R. Carini, M. G. De Cesaris, G. Bellomo, and E. Albano, "Intracellular Na+ accumulation and hepatocyte injury during cold storage," Transplantation, vol. 68, no. 2, pp. 294-297, 1999.
34. R. Carini, M. G. de Cesaris, R. Splendore, M. Bagnati, G. Bellomo, and E. Albano, "Alterations ofNa+ homeostasis in hepatocyte reoxygenation injury," Biochimica et Biophysica Acta, vol. 1500, no. 3, pp. 297-305, 2000.
35. R. Carini, R. Autelli, G. Bellomo, and E. Albano, "Alterations of cell volume regulation in the development of hepatocyte necrosis," Experimental Cell Research, vol. 248, no. 1, pp. 280-293, 1999.
36. R. Carini, R. Castino,M. G. de Cesaris et al., "Preconditioninginduced cytoprotection in hepatocytes requires Ca2+-dependent exocytosis of lysosomes," Journal of Cell Science, vol. 117, part 7, pp. 1065-1077, 2004.
37. R. Carini, N. F. Trincheri, E. Alchera et al., "PI3K-dependent lysosome exocytosis in nitric oxide-preconditioned hepatocytes," Free Radical Biology and Medicine, vol. 40, no. 10, pp. 1738-1748, 2006.
38. G. L. Semenza, "Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology," Trends inMolecularMedicine, vol. 7, no. 8, pp. 345-350, 2001.
39. A. Amador, L. Grande, J. Mart et al., "Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial," American Journal of Transplantation, vol. 7, no. 9, pp. 2180-2189, 2007.
40. E. Alchera, L. Tacchini, C. Imarisio et al., "Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells," Hepatology, vol. 48, no. 1, pp. 230-239, 2008.
41. A. E. Reid, "Nonalcoholic steatohepatitis,"Gastroenterology, vol. 121, no. 3, pp. 710-723, 2001.
42. E. M. Brunt, "Nonalcoholic steatohepatitis: definition and pathology," Seminars in Liver Disease, vol. 21, no. 1, pp. 3-16, 2001.
43. M. J. J. Chu, A. J. R. Hickey, A. R. J. Phillips, and A. S. J. R. Bartlett, "The impact of hepatic steatosis on hepatic ischemiareperfusion injury in experimental studies: a systematic review," BioMed Research International, vol. 2013, Article ID 192029, 12 pages, 2013.
44. V. E. de Meijer, B. T. Kalish, M. Puder, and J. N. M. Jzermans, "Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection," British Journal of Surgery, vol. 97,no. 9, pp. 1331-1339, 2010.
45. M. Selzner, H. A. RüDiger, D. Sindram, J. Madden, and P.-A. Clavien, "Mechanisms of ischemic injury are different in the steatotic and normal rat liver," Hepatology, vol. 32, no. 6, pp. 1280-1288, 2000.
46. M. Domenicali, G. Vendemiale, G. Serviddio et al., "Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status," Digestive and Liver Disease, vol. 37, no. 9, pp. 689-697, 2005.
47. G. Serviddio, F. Bellanti, R. Tamborra et al., "Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury," Gut, vol. 57, no. 7, pp. 957-965, 2008.
48. A. Serafn, J. Roselló-Catafau, N. Prats, C. Xaus, E. Gelp, and C. Peralta, "Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat," American Journal of Pathology, vol. 161, no. 2, pp. 587-601, 2002.
49. B. A. Neuschwander-Tetri, "Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites," Hepatology, vol. 52, no. 2, pp. 774-788, 2010.
50. E. Fabbrini, S. Sullivan, and S. Klein, "Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications," Hepatology, vol. 51, no. 2, pp. 679-689, 2010.
51. C. Imarisio, E. Alchera, S. Sutti et al., "Adenosine A2 receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats," Clinical Science, vol. 123, no. 5, pp. 323-332, 2012.
52. G. Mandili, E. Alchera, S. Merlin et al., "Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/ reperfusion damage and protection by A2aR stimulation," Journal of Hepatology, vol. 62, no. 3, pp. 573-580, 2015.
53. C. Peralta, M. B. Jiménez-Castro, and J. Gracia-Sancho, "Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu," Journal ofHepatology, vol. 59,no. 5, pp. 1094-1106, 2013.
54. U. Rauen, B. Elling, E. R. Gizewski, H.-G. Korth, R. Sustmann, and H. De Groot, "Involvement of reactive oxygen species in the preservation injury to cultured liver endothelial cells," Free Radical Biology & Medicine, vol. 22, no. 1-2, pp. 17-24, 1996.
55. L. Russo, J. Gracia-Sancho, H. Garcá-Calderó et al., "Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers," Hepatology, vol. 55, no. 3, pp. 921-930, 2012.
56. H. Jaeschke and B. L. Woolbright, "Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species," Transplantation Reviews, vol. 26,no. 2, pp. 103-114, 2012.
57. Y. Wang, J. Shen, X. Xiong et al., "Remote ischemic preconditioning protects against liver ischemia-reperfusion injury via heme oxygenase-1-induced autophagy," PLoS ONE, vol. 9, no. 6, Article ID e98834, 2014.
58. S. Kageyama, K. Hata, H. Tanaka et al., "Intestinal ischemic preconditioning ameliorates hepatic ischemia/reperfusion injury in rats: role of heme oxygenase 1 in the second window of protection," Liver Transplantation, vol. 21, no. 1, pp. 112-122, 2015.
59. J. C. Cutrn, M.-G. Perrelli, B. Cavalieri, C. Peralta, J. Rosell Catafau, and G. Poli, "Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning," Free Radical Biology & Medicine, vol. 33, no. 9, pp. 1200-1208, 2002.
60. M. Glanemann, B. Vollmar, A. K. Nussler, T. Schaefer, P. Neuhaus, and M. D. Menger, "Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state," Journal of Hepatology, vol. 38, no. 1, pp. 59-66, 2003.
61. R. S. Koti,W. Yang, G. Glantzounis, A. Quaglia, B. R. Davidson, and A. M. Seifalian, "Effect of ischaemic preconditioning on hepatic oxygenation, microcirculation and function in a rat model of moderate hepatic steatosis," Clinical Science, vol. 108, no. 1, pp. 55-63, 2005.
62. W. Y. Lee and S. M. Lee, "Ischemic preconditioning protects post-ischemic oxidative damage to mitochondria in rat liver," Shock, vol. 24, no. 4, pp. 370-375, 2005.
63. C. E. Müller and K. A. Jacobson, "Recent developments in adenosine receptor ligands and their potential as novel drugs," Biochimica et Biophysica Acta, vol. 1808, no. 5, pp. 1290-1308, 2011.
64. R. C. Hendel, T. M. Bateman, M. D. Cerqueira et al., "Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging," Journal of the American College of Cardiology, vol. 46, no. 11, pp. 2069-2075, 2005.
65. C. A. Thompson, "FDA approves pharmacologic stress agent," American Journal of Health-System Pharmacy, vol. 65, no. 10, article 890, 2008.
66. W. M. Bernhardt, M. S. Wiesener, P. Scigalla et al., "Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD," Journal of the American Society of Nephrology, vol. 21, no. 12, pp. 2151-2156, 2010.
67. H. Malhi and G. J. Gores, "Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease," Seminars in LiverDisease, vol. 28, no. 4, pp. 360-369, 2008.